[ Price : $8.95]
For the second time in a year, FDA inspects contract manufacturer Catalents Brussels, Belgium, manufacturing facility.[ Price : $8.95]
Federal Register notice: FDA extends the comment period for a 6/28 proposed rule entitled Nonprescription Drug Product With an Add...[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance entitled Select Updates for the Breakthrough Devices Program Guidanc...[ Price : $8.95]
Federal Register notice: FDA makes available a final guidance entitled Multiple Endpoints in Clinical Trials.[ Price : $8.95]
Federal Register notice: FDA extends the period before it intends to begin enforcing a statutory 5% limit on distribution of compo...[ Price : $8.95]
Federal Register notice: FDA announces the continuation of its paired meeting program that aims to advance the use of complex inno...[ Price : $8.95]
FDA posts a final guidance entitled Human Gene Therapy for Neurodegenerative Diseases.[ Price : $8.95]
FDA accepts for review a Bristol Myers Squibb supplemental NDA for Camzyos (mavacamten) for an expanded indication to reduce the n...